LEUKEMIA IN ENGLISH
watch my youtube video to understand this topic in easy way-
https://www.youtube.com/watch?v=7O-aSNvU_ig
LEUKEMIA-
Leukemia is defined neoplastic
proliferation of any one type of blood cell mainly granulocyte, monocyte or
lymphocyte. The defect originates in the hematopoietic stem cell, the myeloid,
or the lymphoid stem cell. In other words we can say that leukemia is an
unregulated proliferation of leukocytes in the bone marrow or blood cancer.
CLASSIFICATION OF LEUKEMIA-
The leukemias are commonly classified
according to the stem cell line involved, either lymphoid or myeloid. They are
further classified as either acute or chronic.
ACUTE MYELOID
LEUKEMIA-
Acute Myeloid Leukemia results from a
defect in the hematopoietic stem cell that differentiates into all myeloid
cells: monocytes, granulocytes (neutrophils, basophils, eosinophils), erythrocytes,
and platelets.
In prognosis is Patient’s age is a
significant factor. Patients who are younger may survive for more years after diagnosis of AML
CLINICAL MANIFESTATIONS OF AML-
Ø Due to proliferation of abnormal cells, production of normal blood cells is
reduced that results in following clinical manifestations-
Ø Fever as infection due to
neutropenia
Ø weakness and fatigue due to anemia,
and
Ø bleeding tendencies (GI, pulmonary, and intracranial bleedings are more
common) due to thrombocytopenia.
Ø Petechiae and purpura on lower extremities to thrombocytopenia
Ø Pain from an enlarged liver or spleen.
Ø Pain in gums
Ø Bone pain due to expansion of marrow.
Ø Complications of AML include bleeding and infection, the major causes of
death.
TREATMENT OF AML-
Treatment of AML includes aggressive
administration of chemotherapy. It is also called as induction therapy. It
usually requires hospitalization for several weeks. Induction therapy typically
involves high doses of cytarabine and daunorubicin or mitoxantrone or idarubicin. The aim of induction therapy
is to eradicate the leukemic cells.
Supportive treatment consists of-
administering blood products ( RBCs and
platelets)
promptly treating infections.
The use of granulocytic growth factors,
either G-CSF or GM-CSF can stimulate the bone marrow to produce
normal leukocytes more quickly.
Another treatment option is Bone Marrow
Transplant or Peripheral Blood Stem Cell Transplant.
CHRONIC MYELOID LEUKEMIA-
Chronic Myeloid Leukemia is caused by a
mutation in the myeloid stem cell. In this type of leukemia Normal myeloid
cells continue to be produced, but there is a
increase in the production of abnormal cells. In 90% to 95% of patients
with CML, a section of DNA is missing from chromosome 22.
CLINICAL MANIFESTATIONS
OF CML-
Due to uncontrolled proliferation of
cells, the marrow expands into the cavities of long bones (eg, the femur), and
cells are also formed in the liver and spleen (extramedullary hematopoiesis),
resulting in enlargement of these organs and later become painful. Other
symptoms includes shortness of breath, confusion, malaise, anorexia, and weight
loss
TREATMENT OF CML-
Treatment of CML includes An oral
formulation of a tyrosine kinase inhibitor, imatinib mesylate. Imatinib therapy
appears to be most useful in the chronic phase of the illness. Another
treatment option is Bone Marrow Transplant or Peripheral Blood Stem Cell
Transplant.
ACUTE LYMPHOID LEUKEMIA-
Acute Lymphoid Leukemia or Acute
Lymphocytic Leukemia is caused by an uncontrolled proliferation of immature
cells (lymphoblasts) from the lymphoid stem cell. B lymphocyte ALL found in
approximately 75% of cases and
T-lymphocyte ALL occurs in approximately 25% of cases. ALL is most common in
young children
CLINICAL MANIFESTATIONS
OF ALL-
Ø Due to uncontrolled proliferation of immature cells, the production of
normal cells decreases which results in clinical manifestations such as
Ø pain from an enlarged liver or spleen and bone pain.
Ø The central nervous system involvement may result in headache and vomiting
.
TREATMENT OF ALL-
Treatment of ALL includes preventive
cranial irradiation or intrathecal chemotherapy with methotrexate, Because ALL
frequently invades the central nervous system. Systemic chemotherapy involves
use of anthracyclines along with corticosteroids. Another treatment option is
Bone Marrow Transplant or Peripheral Blood Stem Cell Transplant.
CHRONIC LYMPHOID
LEUKEMIA-
Chronic Lymphoid Leukemia or chronic
Lymphocytic Leukemia is common in older people. It is mainly a malignancy of B
lymphocyte, T lymphocyte involvement is rare. In contrast to the acute forms of
lymphoid leukemia, most of the leukemia cells in CLL are fully mature.
CLINICAL MANIFESTATIONS
OF CLL-
Ø Most patients of CLL are asymptomatic. Sign and symptoms includes-
Ø fever,
Ø Drenching sweats (especially at night),
Ø Unintentional weight loss.
Ø Life-threatening infections
Ø painful lymphadenopathy
TREATMENT OF CLL-
Treatment of CLL includes the
chemotherapy agents such as fludarabine
and cyclophosphamide which are often given in combination with the
monoclonal antibody rituximab. Bacterial infections are
common in patients with CLL, and IV treatment with immunoglobulin may be given
to selected patients with recurrent infection.
DIAGNOSITIC
INVESTIGATIONS-
Ø History and Physical examination. (presence of clinical manifestations of
leukemias)
Ø In all types of leukemias blood investigations are very important for
diagnosis such as
Ø Complete blood count
Ø Bone marrow biopsy for confirming the diagnosis and type of leukemia.
NURSING MANAGEMENT-
Ø Proper assessment is done by health history and physical examination and a
nursing care plan is prepared.
Ø Closely monitor the client for signs
of bleeding and take steps to control bleeding if it occurs.
Ø Apply direct pressure to control bleeding.
Ø For epistaxis, position patient in high Fowler’s
position, apply ice pack to back of neck and direct pressure to nose.
Ø Notify physician for prolonged bleeding (eg, unable to
stop within 10 minutes).
Ø Administer platelets, fresh-frozen plasma, packed red
blood cells, as prescribed.
Ø All medications are given as prescribed and the patient’s response is and
recorded in nurses notes.
Ø The patient should be encouraged to discuss and to participate in the
management of leukemia and ask their concerns.
Ø Fatigue is a very common
symptom of leukemia. Nursing
interventions should focus on assisting the patient to establish a balance
between activity and rest.
Ø Use of a high-efficiency particulate air (HEPA) filter
mask can permit the patient to ambulate outside the room despite severe
neutropenia and risk for
infection.
Ø Patients should be encouraged to sit up in a chair while
awake rather than staying in bed; even this simple activity can improve the
patient’s tidal volume and enhance circulation.
Ø Intake and output need to be measured accurately, and
daily weights should also be monitored. The patient should be assessed for
signs of dehydration as well as fluid overload.
Ø The patient should be encouraged to do as much as
possible to preserve mobility and function as well as self-esteem, he should be
encouraged to maintain personal hygiene,
himself.
Ø The patient and family need to have a clear understanding
of the disease, the prognosis, and how to monitor for complications or
recurrence. The nurse ensures that this
information is provided.
Ø the nurse
should respect the patient’s choices about treatment, including measures
to prolong life and other end-of-life measures.
Ø Being diagnosed with
leukemia can be extremely frightening. Providing emotional support and
discussing the uncertain future are crucial to alleviate anxiety.
Ø During discharge planning and health education patient and family should focus on the
disease, its treatment, home care and certainly the resulting significant risk
of infection and follow up care.
No comments:
Post a Comment